PROTEOLYTIC RELEASE AND CRYSTALLIZATION OF THE RNASE-H DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE

被引:0
作者
HOSTOMSKA, Z
MATTHEWS, DA
DAVIES, JF
NODES, BR
HOSTOMSKY, Z
机构
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The RNase H domain of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase was released from recombinant DHFR-RNase H fusion protein by the action of HIV-1 protease and crystallized as large trigonal prisms that diffract x-rays to at least 2.4-angstrom resolution. The protease cleavage occurred 18 residues away from the Phe440-Tyr441 site reported to be processed during maturation of the reverse transcriptase heterodimer. Mutagenesis of the protease-sensitive region (residues 430-440), which is part of the crystallized domain, indicates that any alteration of the wild-type sequence results in increased proteolysis of the p66 subunit. A model of asymmetric processing in HIV-1 reserve transcriptase which involves partial unfolding of the RNase H domain is proposed based on these results and the recently reported three-dimensional structure of this domain.
引用
收藏
页码:14697 / 14702
页数:6
相关论文
共 50 条
  • [31] DOMAIN-STRUCTURE OF THE HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
    LEDERER, H
    SCHATZ, O
    MAY, R
    CRESPI, H
    DARLIX, JL
    LEGRICE, SFJ
    HEUMANN, H
    [J]. EMBO JOURNAL, 1992, 11 (03) : 1131 - 1139
  • [32] DOUBLE-STRANDED RNA-DEPENDENT RNASE ACTIVITY ASSOCIATED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    BENARTZI, H
    ZEELON, E
    GORECKI, M
    PANET, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (03) : 927 - 931
  • [33] THE EFFECTS OF CYSTEINE MUTATIONS ON THE CATALYTIC ACTIVITIES OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    LOYA, S
    TAL, R
    HUGHES, SH
    HIZI, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (20) : 13879 - 13883
  • [34] INHIBITION OF HEAT INACTIVATION OF REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY SEROPOSITIVE SERA
    NAGUMO, T
    TAKEUCHI, Y
    HOSHINO, H
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (06): : 594 - 600
  • [35] HIGH-AFFINITY SSDNA INHIBITORS OF THE REVERSE-TRANSCRIPTASE OF TYPE-1 HUMAN-IMMUNODEFICIENCY-VIRUS
    SCHNEIDER, DJ
    FEIGON, J
    HOSTOMSKY, Z
    GOLD, L
    [J]. BIOCHEMISTRY, 1995, 34 (29) : 9599 - 9610
  • [36] ANALYSIS OF MUTATIONS AT POSITION-184 IN REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    BOYER, PL
    HUGHES, SH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) : 1624 - 1628
  • [37] THE BINDING OF A NOVEL BISHETEROARYLPIPERAZINE MEDIATES INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    DUEWEKE, TJ
    KEZDY, FJ
    WASZAK, GA
    DEIBEL, MR
    TARPLEY, WG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (01) : 27 - 30
  • [38] INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE BY 3'-BLOCKED OLIGONUCLEOTIDE PRIMERS
    AUSTERMANN, S
    KRUHOFFER, M
    GROSSE, F
    [J]. BIOCHEMICAL PHARMACOLOGY, 1992, 43 (12) : 2581 - 2589
  • [39] MUTATIONAL ANALYSIS OF RESIDUE-190 OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    KLEIM, JP
    BENDER, R
    KIRSCH, R
    MEICHSNER, C
    PAESSENS, A
    RIESS, G
    [J]. VIROLOGY, 1994, 200 (02) : 696 - 701
  • [40] SPECIFIC-INHIBITION OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND THE CHIMERIC ENZYMES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 BY NONNUCLEOSIDE INHIBITORS
    HIZI, A
    TAL, R
    SHAHARABANY, M
    CURRENS, MJ
    BOYD, MR
    HUGHES, SH
    MCMAHON, JB
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) : 1037 - 1042